Prelude Therapeutics (PRLD) Stock Chart & Stock Price History → Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad) Free PRLD Stock Alerts $3.75 -0.03 (-0.79%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Prelude Therapeutics Stock Price Performance5 Day Performance+1.63%1 Month Performance+4.46%3 Month Performance-15.16%6 Month Performance+11.61%Year-To-Date Performance-12.18%1 Year Performance-32.25% Receive PRLD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. PRLD Stock Chart for Saturday, June, 8, 2024 PRLD Chart by TradingView Prelude Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$3.78$3.75-0.79%$3.79$3.6417,970 shs$205.99 million06/06/2024$3.77$3.78+0.27%$3.82$3.7034,467 shs$207.64 million06/05/2024$3.56$3.77+5.90%$3.88$3.5122,632 shs$207.09 million06/04/2024$3.69$3.56-3.52%$3.76$3.4658,920 shs$195.55 million06/03/2024$3.85$3.69-4.16%$4.03$3.6331,472 shs$202.69 million05/31/2024$3.87$3.85-0.52%$3.94$3.5985,083 shs$211.48 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$3.32$3.87+16.57%$4.13$3.3768,258 shs$212.58 million05/29/2024$3.71$3.32-10.51%$3.95$3.3272,944 shs$182.37 million05/28/2024$4.09$3.71-9.29%$4.10$3.7074,725 shs$203.79 million05/27/2024$4.09$4.09$4.28$3.9125,700 shs$224.66 million05/24/2024$4.04$4.09+1.24%$4.28$3.9125,733 shs$224.66 million05/23/2024$4.12$4.04-1.94%$4.35$3.8941,746 shs$221.92 million05/22/2024$4.09$4.12+0.73%$4.42$3.8617,612 shs$226.31 million05/21/2024$4.12$4.09-0.73%$4.31$4.0229,802 shs$224.66 million05/20/2024$4.00$4.12+3.00%$4.21$3.9021,967 shs$226.31 million05/17/2024$4.28$4.00-6.54%$4.37$3.9940,740 shs$168.32 million05/16/2024$4.00$4.28+7.00%$4.42$3.8651,688 shs$180.10 million05/15/2024$3.86$4.00+3.63%$4.21$3.8448,088 shs$168.32 million05/14/2024$3.80$3.86+1.58%$4.06$3.7227,733 shs$162.43 million05/13/2024$3.73$3.80+1.88%$3.95$3.7521,629 shs$159.90 million05/10/2024$4.07$3.73-8.35%$4.04$3.6953,678 shs$156.96 million05/09/2024$3.59$4.07+13.37%$4.08$3.6252,898 shs$171.27 million05/08/2024$3.70$3.59-2.97%$3.93$3.5941,344 shs$151.07 million05/07/2024$3.83$3.70-3.39%$4.12$3.6636,872 shs$155.70 million05/06/2024$3.86$3.83-0.78%$4.06$3.8322,713 shs$161.17 million05/03/2024$3.99$3.86-3.26%$4.11$3.8017,251 shs$162.43 million05/02/2024$3.73$3.99+6.97%$4.02$3.7527,359 shs$167.90 million05/01/2024$3.77$3.73-1.06%$3.80$3.6522,025 shs$156.96 million04/30/2024$3.84$3.77-1.82%$3.86$3.5648,436 shs$207.05 million04/29/2024$4.07$3.84-5.65%$4.09$3.8118,176 shs$210.89 million04/26/2024$4.04$4.07+0.74%$4.07$3.9918,543 shs$223.52 million04/25/2024$3.87$4.04+4.39%$4.09$3.99115,736 shs$221.88 million04/24/2024$3.87$3.87$4.13$3.8728,584 shs$212.54 million04/23/2024$3.85$3.87+0.52%$4.07$3.8724,900 shs$212.54 million04/22/2024$3.72$3.85+3.49%$3.96$3.7550,051 shs$211.44 million04/19/2024$3.44$3.72+8.14%$3.86$3.4557,895 shs$204.30 million04/18/2024$4.18$3.44-17.70%$4.18$3.42112,889 shs$188.93 million04/17/2024$4.91$4.18-14.87%$4.92$4.1268,936 shs$229.57 million04/16/2024$5.63$4.91-12.79%$5.63$4.7938,328 shs$269.66 million04/15/2024$5.62$5.63+0.18%$5.83$5.4289,987 shs$309.20 millionThe new masters of energy (Ad)According to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details.04/12/2024$5.22$5.62+7.66%$5.77$5.1257,997 shs$308.66 million04/11/2024$4.95$5.22+5.45%$5.35$4.8645,169 shs$286.68 million04/10/2024$4.99$4.95-0.80%$5.17$4.6724,121 shs$271.85 million04/09/2024$4.70$4.99+6.17%$5.07$4.5664,215 shs$274.05 million04/08/2024$4.70$4.70$4.82$4.6015,589 shs$258.12 million04/05/2024$4.74$4.70-0.84%$4.98$4.4717,673 shs$258.12 million04/04/2024$4.72$4.74+0.42%$4.84$4.5821,812 shs$260.32 million04/03/2024$4.62$4.72+2.16%$4.76$4.5228,329 shs$259.22 million04/02/2024$4.69$4.62-1.49%$4.65$4.4131,906 shs$253.73 million04/01/2024$4.74$4.69-1.05%$4.93$4.6114,339 shs$257.58 million03/29/2024$4.74$4.74$5.00$4.7232,074 shs$260.32 million03/28/2024$4.77$4.74-0.63%$5.00$4.7232,074 shs$260.32 million03/27/2024$4.61$4.77+3.47%$4.92$4.5633,947 shs$261.97 million03/26/2024$4.61$4.61$4.82$4.4927,359 shs$253.18 million03/25/2024$4.70$4.61-1.91%$4.92$4.5335,697 shs$253.18 million03/22/2024$4.82$4.70-2.49%$4.89$4.6428,969 shs$258.12 million03/21/2024$4.84$4.82-0.41%$4.98$4.7528,586 shs$264.71 million03/20/2024$4.84$4.84$4.94$4.7427,161 shs$265.81 million03/19/2024$4.65$4.84+4.09%$4.94$4.5448,078 shs$265.81 million03/18/2024$4.74$4.65-1.90%$4.92$4.6145,520 shs$255.38 million03/15/2024$4.46$4.74+6.28%$4.75$4.22142,906 shs$260.32 million03/14/2024$4.62$4.46-3.46%$4.63$4.3625,124 shs$244.95 million03/13/2024$4.10$4.62+12.68%$4.66$4.1742,446 shs$253.74 million03/12/2024$4.09$4.10+0.24%$4.19$3.9244,275 shs$225.17 million03/11/2024$4.42$4.09-7.47%$4.42$4.0960,577 shs$224.62 million03/08/2024$4.38$4.42+0.91%$4.45$4.2830,060 shs$242.75 million03/07/2024$4.17$4.38+5.04%$4.45$4.1572,627 shs$240.55 million Related Companies: GH Research Stock Price Chart Tango Therapeutics Stock Price Chart Wave Life Sciences Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart Pliant Therapeutics Stock Price Chart Longboard Pharmaceuticals Stock Price Chart Phibro Animal Health Stock Price Chart Nuvation Bio Stock Price Chart Olema Pharmaceuticals Stock Price Chart AnaptysBio Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.